
800-388-3905
A recent article published in The Journal of Bone and Joint Surgery clearly shows that the Stryker Rejuvenate modular hip implant may be as capable of corroding as its metal-on-metal cousins. This publication is significant because it shows metal-on-metal (MoM) hips are not the only problem. Adverse events were reported with the components in this…
Johnson & Johnson can not dodge an $8.3 million jury award by having a new metal-on-metal hip trial. J&J”s DePuy Orthopaedics division petitioned a California court to have a new trial to offset a March jury award to the metal hip injured patient. Judge J. Stephen Czuleger rejected that motion letting stand the jury ruling…
Johnson & Johnson (J&J) has requested that an $8.3 million judgment against the company over its DePuy metal-on-metal (MoM) hip implant be put on hold. The damaging jury award was rendered in March against J&J’s DePuy Orthopedics division on behalf of plaintiff, Loren Kransky. His metal hip shed cobalt and chromium debris into his implant…
The annual meeting of the 2013 American Academy of Orthopaedic Surgeons (AAOS) in Chicago has just concluded and doctors delivered a mixed report on metal-on-metal hip replacements. In a study presented from New York State’s Hospital for Special Surgery (HSS), researchers found unexplained pain in metal-on-metal (MoM) hip implant patients is more likely due to…
Orthopedic medical device maker Stryker Corp. has received a warning letter from the U.S. Food and Drug Administration (FDA) following a quality control inspection at its Michigan facility in November. The facility is in Portage, Michigan and is home to Stryker Corp’s instruments division, though there are no details about what was found. The letter…
The medical device division of the FDA is acting more like a watchdog than a lapdog according to a new analysis. The Center for Devices and Radiological Health (CDRH) reportedly issued one-third more warning letters in 2011 for dangerous devices than it did in 2008. Since 2007 there has been a 250 percent increase in…
On February 20, 2013 Judge Brian Martinotti held the first case management conference in Bergen County New Jersey. Approximately 50 lawyers attended the conference including counsel for Stryker. Several matters were on the agenda and after all in attendance announced their appearance for the record judge Martinotti issued several rulings that will jumpstart this litigation….
Now that many victims in whom Stryker’s Rejuvenate or ABG II hip implants were placed have been notified the devices have been recalled they face the very difficult decision about what to do. They now know a defective and recalled medical device is inside them. Some have symptoms, some don’t. Many have been to their…
The Stryker Accolade® TMZF femoral stem was approved by the Food & Drug Administration in 2000, through a process called the 510(k) approval process. This is the method used by manufacturers to get a rapid approval for medical devices to be used inside patients. The 510(k) process allows the device manufacturer to file papers with…
When Stryker recalled its Rejuvenate and ABG II hip stems in July of 2012, it penned a letter for doctors to transmit to patients telling them that if they had no symptoms they need not bother seeing the doctor until their next scheduled visit. For many patients who were implanted with these devices, they had…
Call us today. We charge no fee or costs unless we make a recovery for you. The attorneys at Searcy Denney continue to file Stryker lawsuits on behalf of injured parties across the country.
Please click the below button to use our convenient live chat and speak with someone right away.